{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:35:44Z","timestamp":1772825744776,"version":"3.50.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s192235","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T21:36:37Z","timestamp":1550180197000},"page":"159-168","source":"Crossref","is-referenced-by-count":11,"title":["&lt;p&gt;Cost-effectiveness of secukinumab compared to other biologics in the treatment of ankylosing spondylitis in Finland&lt;\/p&gt;"],"prefix":"10.2147","volume":"Volume 11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7794-7495","authenticated-orcid":true,"given":"Timo","family":"Purmonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Puolakka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Gunda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"Martikainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,2]]},"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=48080","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=48080","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T21:36:37Z","timestamp":1550180197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/cost-effectiveness-of-secukinumab-compared-to-other-biologics-in-the-t-peer-reviewed-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ceor.s192235","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}